Journal of Thrombosis and Haemostasis

On this web site you will find information about the Journal and details of its editors.

The aim of the Journal of Thrombosis and Haemostasis team, in partnership with our publisher Blackwell, is to advance science related to thrombosis, bleeding disorders, and vascular biology through the exchange of research across the international community.

We publish high quality, original research reports, state-of-the-art reviews, letters, and invited commentaries and debates on timely topics.

The Journal of Thrombosis and Haemostasis is available in print and online. Click on the journal image to go to the latest issue.

editors' highlights

Key content from recent issues

A debate on the use of fibrinogen concentrate for the management of bleeding: For, by N. Rahe-Meyer and B. Sørensen and against, by Y. Ozier and B. J. Hunt.

Factor XIII: novel structural and functional aspects, Review article by I. Komáromi, Z. Bagoly and L. Muszbek.

Clopidogrel discontinuation and platelet reactivity following coronary stenting, In Focus paper by D. Mylotte, A. Peace, T. Tedesco, F. Mangiacapra, P. Dicker, D. Kenny and D. Foley.

Factor V Leiden as risk factor for preterm birth ? a population-based nested case-control study, Original article by L. M. Hiltunen, H. Laivuori, A. Rautanen, R. Kaaja, J. Kere, T. Krusius, V. Rasi and M. Paunio.

Recombinant Human Tissue Factor Pathway Inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia, In Focus paper by F. E. Van Den Boogaard, X. Brands, M. J. Schultz, M. Levi, J. J. T. H. Roelofs, C. Van?t Veer and T. Van Der Poll.

An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies, Original article by B. De Laat, R. H. W. M. Derksen, G. Reber, J. Musial, J. Swadzba, B. Bozic, S. Cucnik, V. Regnault, R. Forastiero, B. J. Woodhams and Ph. G. De Groot.

TNF Receptor-Associated Factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets, Original article by J. F. Arthur, Y. Shen, E. E. Gardiner, L. Coleman, D. Kenny, R. K. Andrews and M. C. Berndt.